Improving diagnosis

We are working on developing better methods of diagnosis as well as ‘risk assessment’, so treatment can be tailored to individual children and ultimately personalised.

For the best chance of survival, it is vital that cancer in a child is detected as early as possible.

improved diagnosis

Molecular Diagnostics

Program Head, Professor Murray Norris

Improving the diagnosis and treatment of childhood cancers.

Minimal Residual Disease

Group Manager, Dr Rosemary Sutton

Determining the risk of relapse for children with leukaemia.